Skip to main content
VCbacked
Log inGet Started

Watershed Informatics

Cambridge, United States

Watershed Informatics catalyzes discovery by democratizing access to bioinformatics tools for biologists.

$14.5M raised
Mar 2023
Series A
BiotechnologyInformation TechnologyLife Science

Top Investors

Bessemer Venture PartnersAccompliceCanvas VenturesFirsthandVC

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Watershed Informatics

How much funding has Watershed Informatics raised?
Watershed Informatics has raised $14.5M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Who are Watershed Informatics's investors?
Watershed Informatics's investors include Bessemer Venture Partners, Accomplice, Canvas Ventures, FirsthandVC.
Where is Watershed Informatics headquartered?
Watershed Informatics is headquartered in Cambridge, United States.
What does Watershed Informatics do?
Watershed Informatics catalyzes discovery by democratizing access to bioinformatics tools for biologists.
What stage is Watershed Informatics at?
Watershed Informatics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Watershed Informatics — Funding & Investors." VCBacked, March 30, 2023, https://www.vcbacked.co/company/watershed-informatics. Accessed June 3, 2026.
APA
VCBacked. (2023). Watershed Informatics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/watershed-informatics
Wikipedia (cite web)
{{cite web |title=Watershed Informatics — Funding & Investors |url=https://www.vcbacked.co/company/watershed-informatics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong